Aptevo Therapeutics
Stock Forecast, Prediction & Price Target
Aptevo Therapeutics Financial Estimates
Aptevo Therapeutics Revenue Estimates
Aptevo Therapeutics EBITDA Estimates
Aptevo Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $12.29M N/A | $3.11M -74.66% | $0 -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $13.21M Low: $13.21M High: $13.21M avg. 0% | Avg: $57.93M Low: $57.93M High: $57.93M avg. 338.33% | Avg: $77.14M Low: $77.14M High: $77.14M avg. 33.14% |
Net Income
% change YoY
| $-27.31M N/A | $42.66M 256.22% | $-17.41M -140.80% | Avg: $-31.29M Low: $-1.60M High: $-1.60M avg. -79.75% | Avg: $-18.57M Low: $-906.48K High: $-906.48K avg. 40.65% | Avg: $528.31K Low: $528.31K High: $528.31K avg. 102.84% | Avg: $895.35K Low: $895.35K High: $895.35K avg. 69.47% |
EBITDA
% change YoY
| $-21.4M N/A | $-64.92M -203.37% | $-28.31M 56.39% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $-7.93M Low: $-7.93M High: $-7.93M avg. 0% | Avg: $-34.76M Low: $-34.76M High: $-34.76M avg. -338.33% | Avg: $-46.28M Low: $-46.28M High: $-46.28M avg. -33.14% |
EPS
% change YoY
| -$256.35 N/A | $366.71 243.05% | -$62.62 -117.07% | Avg: -$5.77 Low: -$5.77 High: -$5.77 avg. 90.78% | Avg: -$3.26 Low: -$3.26 High: -$3.26 avg. 43.50% | Avg: $1.9 Low: $1.9 High: $1.9 avg. 158.28% | Avg: $3.22 Low: $3.22 High: $3.22 avg. 69.47% |
Operating Expenses
% change YoY
| $33.69M N/A | $31.75M -5.74% | $28.87M -9.05% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $27.46M Low: $27.46M High: $27.46M avg. 0% | Avg: $120.37M Low: $120.37M High: $120.37M avg. 338.33% | Avg: $160.26M Low: $160.26M High: $160.26M avg. 33.14% |
FAQ
What is Aptevo Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 33.30% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -1.60M, average is -31.29M and high is -1.60M.
What is Aptevo Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 92.86% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Aptevo Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 90.51% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$5.77, average is -$5.77 and high is $-5.77.